Stocks / Pharmaceuticals

BMYPharmaceuticals

Bristol-Myers Squibb Co.
$62.901d -1.1%5d -1.6%settled close · 2026-09-17
Mkt cap $117B (3/25)β 0.3352w $43–68Shares 2.04BInd. Pharmaceutical PreparationsNYSE since 1952Emp. 32,500HQ Princeton, NJbms.com
The tape, with the calls on it

Who said what, and what BMY did next

Every dot is a day someone on the record made a call. Hover one to see who. We are not scoring them — the point is that you can see it and judge for yourself.

bullish bearish both sides
Who’s talkingIdea Scout · free

Who’s talking about BMY

3 longlatest 2026-08-04
DateVoiceStanceVenueThesis
2026-08-04Unknown Investment CommitteeBullishCNBC Halftime Final TradesBristol Myers Squibb is exceptionally cheap with a good dividend yield and a real pipeline in cardiovascular…
2025-12-23Andrew BarySenior Editor, Barron'sBullishBarron's RoundtableBristol-Myers is a 'have not' in pharma trading at under 10x PE with nearly a 5% dividend yield and an…
2025-04-11Jenny Harrington (Gilman Hill)CEO, Gilman Hill Asset ManagementBullishThe CompoundBristol-Myers generates $10B+ annual free cash flow for the next three years and trades at 8x forward…
Idea Scout tracks who’s talking across television, podcasts, and interviews — every stance dated to the appearance it came from. Sign up free →
Earnings

Next report: 29 Oct 2026

Confirmed date · consensus EPS 1.74. Reactions below are the next settled session over the prior close.
The options tape

Notable options days

Sessions in the last 120 where BMY’s settled options volume ran ≥ 2× its trailing 20-session baseline, or delta-dollar flow ran ≥ 2.5× — 12 of 120 sessions qualified.

The qualifying dates are the free record. Close, flow, call/LEAPS mix and the 20-session outcome — for every session below — are Brief subscriber content.
DateCloseRVOL Δ$ flow ($M)Call % LEAPS %+20 sess.
2026-09-10
2026-08-19
2026-08-11
2026-08-03
2026-07-30
2026-07-20
2026-07-16
2026-06-30
2026-06-22
2026-05-01
2026-04-01
2026-03-25
+20 sess. = raw price change over the following 20 sessions — not market-adjusted; the tape tells you where to look, not what happens next.
Today’s tape on BMY is in this morning’s Brief. Get The Brief — $20/mo →